[
    [
        {
            "time": "2023-04-15",
            "original_text": "McKesson (MCK) Q4 Earnings and Revenues Surpass Estimates",
            "features": {
                "keywords": [
                    "McKesson",
                    "Q4",
                    "Earnings",
                    "Revenues",
                    "Surpass",
                    "Estimates"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "McKesson (MCK) Q4 Earnings and Revenues Surpass Estimates",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "Does Eli Lilly (NYSE:LLY) Deserve A Spot On Your Watchlist?",
            "features": {
                "keywords": [
                    "Eli",
                    "Lilly",
                    "LLY",
                    "Watchlist"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Does Eli Lilly (NYSE:LLY) Deserve A Spot On Your Watchlist?",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "J&J to Stop Sale of Talc-Based Baby Powder in North America",
            "features": {
                "keywords": [
                    "J&J",
                    "Stop",
                    "Sale",
                    "Talc-Based",
                    "Baby",
                    "Powder",
                    "North",
                    "America"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "consumer goods"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "J&J to Stop Sale of Talc-Based Baby Powder in North America",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]